Benoit Molinie
Associate Director, Clinical Laboratory @Broad Institute of MIT and Harvard
Signup · Get unlimited contacts
WORK HISTORY
Associate Director, Clinical Laboratory @Broad Institute of MIT and Harvard
Boston, MA, US
Associate Director, Clinical Laboratory
EDUCATION
Harvard Medical School
Ph.D. Fellowship, Transcriptional Epigenetic Regulation
Marshall University
Fellowship, Chromatin Epigenetics, Molecular Genetics
The University of Manchester
Doctor of Philosophy (Ph.D.), Developmental Biology And Molecular Genetics
Georgia State University
Bachelor of Science (B.S.), Pre-Medicine/Pre-Medical Studies
SKILLS
ABOUT BENOIT MOLINIE
Proven record of success in academic and corporate research. Internationally recognized expert on cancer, human embryonic stem cell, RNA methylation, Non-Coding RNAs and CircRNAs research. Deep expertise in single cell transcriptomics applications, epitranscriptomics, epigenomics and synthetic biology approaches to protein mutagenesis. Extensive experience in reduction to practice of new protocols, including highly multiplexed processes and screening applications. Developer of numerous novel approaches to analysis of a range of noncoding RNA species such as ssGROseq, ezGROseq, m6A-LAIC-seq and NRAM. Creator of multiple research and production protocols for both clinical and research applications. Author of landmark publications in transcriptional epigenetics/epigenomics. Background includes single cell transcriptomics applications and synthetic biology approaches to protein mutagenesis. Committed to high standards of quality and productivity in all roles and assignments. Dedicated to decipher the emerging role of transcriptional epigenetic regulation in all biological systems. Educational credentials include a PhD in Developmental and Molecular Genetic, postdoctoral fellowship in RNA “epigenetics”.AREA OF EXPERTISE- Scientific leadership and management in genomics - Technology development, from conception and innovation to testing and validation- Epitranscripomics and RNA methylation including RIP-seq, HITS-CLIP, PAR-CLIP, m6A-RIP, m6A-LAIC-seq- Specialized RNA analyses, including GROseq- Epigenomic approaches, including ChIP-chip and ChIP-seq- Transcriptomics methods and analyses- Single cell RNA-seq methods and technologies - Protein mutagenesis by MITE-seq- RNA interference (Si RNA and Sh RNA)- CRISPR and TALEN knockout technologies- Training and mentoring- Communication & interpersonal skillsMulti-lingual (French, English, Spanish)
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.